EcoDrugPlus

Cyclin Dependent Kinase 6

Ensembl ID : ENSAMXG00000014264
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSAMXG00000008454
Gene Symbol: CDK7
3 Cross references
219 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSAMXG00000013366
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSAMXG00000026474
Gene Symbol: CYSLTR1
3 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSAMXG00000034539
Gene Symbol: CDA
3 Cross references
163 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSAMXG00000032243
Gene Symbol: CDAB
1 Cross references
199 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSAMXG00000011960
Gene Symbol: LOC103044660
3 Cross references
195 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSAMXG00000034235
Gene Symbol: LOC103030124
2 Cross references
561 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSAMXG00000035565
Gene Symbol: LOC103031034
3 Cross references
601 Possible Orthologues:

Cytochrome P450 3a56-Like

Ensembl ID : ENSAMXG00000012560
Gene Symbol: LOC103031560
2 Cross references
585 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSAMXG00000016747
Gene Symbol: CYP19A1
2 Cross references
246 Possible Orthologues:

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1a

Ensembl ID : ENSAMXG00000042616
Gene Symbol: CYP19A1A
1 Cross references
255 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).